<- Go Home

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. develops, manufactures, and supplies prescription and over-the-counter pharmaceutical products, including active pharmaceutical ingredients and finished dosage forms. The company produces medications in various forms such as tablets, capsules, suspensions, solutions, creams, and ointments, and synthesizes active pharmaceutical ingredients for use in its own products and for sale. Its medications address therapeutic areas including dermatology, cardiology, pediatrics, and neurology, and are available under its own label or as private label offerings. The company engages in research and development of proprietary and off-patent pharmaceuticals. It serves healthcare professionals, industry professionals, and patients in sectors such as dermatology, cardiology, pediatrics, and neurology, supplying products to clients in the United States, Canada, Israel, and other international markets. Taro Pharmaceutical Industries Ltd. was founded in 1959 and is based in Haifa, Israel.

Market Cap

$1.6B

Volume

44.8K

Cash and Equivalents

$362.9M

EBITDA

$38.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$305.0M

Profit Margin

48.47%

52 Week High

$45.76

52 Week Low

$32.67

Dividend

N/A

Price / Book Value

0.90

Price / Earnings

29.98

Price / Tangible Book Value

0.91

Enterprise Value

$277.7M

Enterprise Value / EBITDA

7.23

Operating Income

$7.3M

Return on Equity

3.06%

Return on Assets

0.21

Cash and Short Term Investments

$879.4M

Debt

N/A

Equity

$1.8B

Revenue

$629.2M

Unlevered FCF

$21.0M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches